Related Experiment Video
Updated: Oct 5, 2025
12:37
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
13.5K
Phosphodiesterase-1 in the cardiovascular system
1Division of Vascular Pharmacology and Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Cellular Signalling
|January 23, 2022
Summary
Phosphodiesterase 1 (PDE1) regulates cyclic nucleotide signaling in cardiovascular cells. Inhibiting PDE1 offers a promising therapeutic strategy for cardiovascular diseases by modulating cell function.
Area of Science:
- Cardiovascular Biology
- Molecular Pharmacology
- Cell Signaling
Background:
- Phosphodiesterases (PDEs) control cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels.
- Specific PDE subtypes and isoforms regulate signaling within distinct cellular nanodomains.
- Regulation is cell-type and condition-dependent, influencing cellular functions.
Purpose of the Study:
- To review the structure, function, and therapeutic potential of phosphodiesterase 1 (PDE1).
- To discuss PDE1 isoform roles in vascular smooth muscle, cardiac myocytes, and fibroblasts.
- To explore PDE1's relevance in cardiovascular disease and as a drug target.
Main Methods:
- Literature review focusing on PDE1 structure and function.
- Analysis of PDE1 isoform roles in cardiovascular cell types.
- Examination of conditions modulating PDE1 activity and clinical implications.
Main Results:
- PDE1 isoforms influence vasomotor control, cardiac contractility, cell growth, fibrosis, and senescence.
- PDE1 activity is modulated by proliferative status, cell stress, and aging.
- Nanodomain localization and signaling mechanisms are critical for PDE1 function.
Conclusions:
- PDE1 plays a significant role in cardiovascular physiology and pathophysiology.
- Targeting PDE1 with inhibitors presents a prospective therapeutic avenue for cardiovascular diseases.
- Understanding PDE1's cell-specific functions and nanodomain regulation is key for drug development.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.1K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
268
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
268
01:28Nitric Oxide Signaling Pathway
5.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
02:54Protein Kinases and Phosphatases
13.6K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.6K
01:29Pathophysiology of Cardiac Performance
845
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
845
01:23Antihypertensive Drugs: Vasodilators
693
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
693